Free Content Expression of immediate early gene pip92 during anisomycin-induced cell death is mediated by the JNK- and p38-dependent activation of Elk1

Authors: Chung, Kwang C.1; Kim, Sung M.2; Rhang, Sungin1; Lau, Lester F.3; Gomes, Ignatius; Ahn, Young S.1

Source: FEBS Journal, Volume 267, Number 15, August 2000 , pp. 4676-4684(9)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

You have access to the full text article on a website external to ingentaconnect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Abstract:

We report here that immediate early gene pip92 is expressed during anisomycin-induced cell death in fibroblast NIH3T3 cells. To determine the mechanism by which this occurs and to identify downstream signaling pathways, we investigated the induction of the pip92 promoter. The activation of pip92 by anisomycin is mediated by the activation of MAP kinases, such as JNK and p38 kinase, but not ERK. Deletion analysis of the pip92 promoter indicated that pip92 activation occurs primarily within the region containing a serum response element (SRE). Further analysis of the SRE using a heterologous thymidine kinase promoter showed that both an Ets and CArG-like site are required for anisomycin-induced pip92 expression. Elk1, which binds to the Ets site, was phosphorylated by the JNK- and p38-dependent pathways and the phosphorylation of Elk1-GAL4 fusion proteins by these pathways was sufficient for the transactivation. Overall, this study suggested that different MAPK pathways are involved in the expression of immediate early gene pip92 by growth factors and environmental stresses.

Keywords: pip92; anisomycin; cell death; MAP kinase; Elk1

Document Type: Research article

DOI: http://dx.doi.org/10.1046/j.1432-1327.2000.01517.x

Affiliations: 1: Department of Pharmacology and Brain Research Institute, Yonsei University College of Medicine, Seoul, Korea; 2: Research Institute of Science and Technology, Hong-Ik University, Seoul, Korea; 3: Department of Genetics, University of Illinois College of Medicine, Chicago, Illinois, USA;

Publication date: 2000-08-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page